Toggle navigation
Home
Search
Services
Blog
Contact
About
Nerve Growth Factor Delivery for Alzheimer's Disease
Bishop, Katherine M.
Ceregene, Inc., San Diego, CA, United States
Search 3 grants from Katherine Bishop
Search grants from Ceregene, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Use of the Scout Device in Evaluation of Disbetes Risk in Women with Pcos
Follow Up of the Multimodal Treatment Study of Children with Attention-278012007
Dose Range Study of Remacemide as Adjunct to Levodopa in Parkinson's Disease
Transcriptional Mechanisms of Th Gene Expression
Presidential Young Investigator Award: Architectures and Synthesis for Digital Signal Processing
Recently added grants:
Post-Initiation control of transcription in inflammatory macrophages
The variable disease potential of group A Streptococcus isolates: a link to puerperal infections
T Cell Recognition of Disulfide Modified Antigens
Inititation and elongation of HDV RNAs
Apply an imaging flow cytometry method to screen chemical libraries for identifying and repurposing novel drugs against coccidioidomycosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
3R44NS044652-02S1
Application #
6844444
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Murphy, Diane
Project Start
2002-09-30
Project End
2005-08-31
Budget Start
2003-09-30
Budget End
2004-08-31
Support Year
2
Fiscal Year
2004
Total Cost
$199,878
Indirect Cost
Institution
Name
Ceregene, Inc.
Department
Type
DUNS #
019139414
City
San Diego
State
CA
Country
United States
Zip Code
92121
Related projects
NIH 2004
R44 NS
Nerve Growth Factor Delivery for Alzheimer's Disease
Bartus, Raymond / Ceregene, Inc.
$157,635
NIH 2004
R44 NS
Nerve Growth Factor Delivery for Alzheimer's Disease
Bishop, Katherine M. / Ceregene, Inc.
$199,878
NIH 2003
R44 NS
Nerve Growth Factor Delivery for Alzheimer's Disease
Bishop, Katherine M. / Ceregene, Inc.
$701,862
Publications
Bishop, Kathie M; Hofer, Eva K; Mehta, Arpesh et al.
(2008)
Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons.
Exp Neurol 211:574-84
Comments
Be the first to comment on Katherine Bishop's grant